Predictive Effect of System Inflammation Response Index for Progression of Chronic Kidney Disease in Non-Dialyzing Patient

References

• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
   PubMed Web of Science ®Google Scholar
• Yeh HC, Lo YC, Ting IW, et al. 24-hour serum creatinine variation associates with short- and long-term all-cause mortality: a real-world insight into early detection of acute kidney injury. Sci Rep. 2020;10(1):6552. doi:10.1038/s41598-020-63315-x
   PubMed Web of Science ®Google Scholar
• Xs G, Sq C, Cy D, et al. Association of post-procedural early (within 24h) increases in serum creatinine with all-cause mortality after coronary angiography. Clin Chim Acta. 2017;474:96–101. doi:10.1016/j.cca.2017.08.036
   PubMed Web of Science ®Google Scholar
• Losito A, Nunzi E, Pittavini L, et al. Cardiovascular morbidity and long term mortality associated with in hospital small increases of serum creatinine. J Nephrol. 2018;31(1):71–77. doi:10.1007/s40620-017-0413-y
   PubMed Web of Science ®Google Scholar
• Mh B, Ristl R, Neugebauer T, et al. Very early changes in serum creatinine are associated with 30-day mortality after cardiac surgery: a cohort study. Eur J Anaesthesiol. 2020;37(10):898–907.
   PubMed Web of Science ®Google Scholar
• Stuveling EM, Hillege HL, Bakker SJ, et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63(2):654–661. doi:10.1046/j.1523-1755.2003.00762.x
   PubMed Web of Science ®Google Scholar
• Chen S, Liu H, Liu X, et al. Central obesity, C-reactive protein and chronic kidney disease: a community-based cross-sectional study in southern China. Kidney Blood Press Res. 2013;37(4–5):392–401. doi:10.1159/000355718
   PubMed Web of Science ®Google Scholar
• Sesso HD, Wang L, Buring JE, et al. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2007;49(2):304–310. doi:10.1161/01.HYP.0000252664.24294.ff
   PubMed Web of Science ®Google Scholar
• Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006;15(2):152–158. doi:10.1097/01.mnh.0000203189.57513.76
   PubMed Web of Science ®Google Scholar
• Boos CJ, Lip GY. Is hypertension an inflammatory process? Curr Pharm Des. 2006;12(13):1623–1635. doi:10.2174/138161206776843313
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Papa F. Systemic inflammation, blood pressure, and stroke outcome. J Clin Hypertens. 2006;8(3):187–194. doi:10.1111/j.1524-6175.2005.04590.x
   Google Scholar
• Sevencan NO, Ozkan AE. Associations between neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, albuminuria and uric acid and the estimated glomerular filtration rate in hypertensive patients with chronic kidney disease stages 1–3. Arch Med Sci. 2019;15(5):1232–1239. doi:10.5114/aoms.2018.76262
   PubMed Web of Science ®Google Scholar
• Jakubzick C, Gautier EL, Gibbings SL, et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity. 2013;39(3):599–610. doi:10.1016/j.immuni.2013.08.007
   PubMed Web of Science ®Google Scholar
• Kuo YT, Wang YY, Lin SY, et al. Age and sex differences in the relationship between neutrophil-to-lymphocyte ratio and chronic kidney disease among an adult population in Taiwan. Clin Chim Acta. 2018;486:98–103. doi:10.1016/j.cca.2018.07.025
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang K, Zheng H, et al. Monocyte lymphocyte ratio predicts the new-onset of chronic kidney disease: a cohort study. Clin Chim Acta. 2020;503:181–189. doi:10.1016/j.cca.2019.11.021
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Duman TT, et al. Monocyte lymphocyte ratio as a predictor of Diabetic Kidney Injury in type 2 diabetes mellitus; the MADKID study. J Diabetes Metab Disord. 2020;19(2):997–1002. doi:10.1007/s40200-020-00595-0
   PubMed Web of Science ®Google Scholar
• Yoshitomi R, Nakayama M, Sakoh T, et al. High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail. 2019;41(1):238–243. doi:10.1080/0886022X.2019.1595645
   PubMed Web of Science ®Google Scholar
• Xia Y, Xia C, Wu L, et al. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023;12(3):1128. doi:10.3390/jcm12031128
   PubMed Web of Science ®Google Scholar
• Jin Z, Wu Q, Chen S, et al. The Associations of Two Novel Inflammation Indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140. doi:10.2147/JIR.S283835
   PubMed Web of Science ®Google Scholar
• Lin KB, Fan FH, Cai MQ, et al. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022;27(1):106. doi:10.1186/s40001-022-00733-9
   PubMed Web of Science ®Google Scholar
• Drawz PE, Beddhu S, Bignall ON, et al. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the management of blood pressure in CKD. Am J Kidney Dis. 2022;79(3):311–327. doi:10.1053/j.ajkd.2021.09.013
   PubMed Web of Science ®Google Scholar
• de Boer IH, Caramori ML, Chan JC, et al. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98(4S):S1–S115. doi:10.1016/j.kint.2020.06.019
   PubMedGoogle Scholar
• American Diabetes Association.11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S151–S167. doi:10.2337/dc21-S011
   PubMed Web of Science ®Google Scholar
• Tsai IT, Wu CC, Hung WC, et al. FABP1 and FABP2 as markers of diabetic nephropathy. Int J Med Sci. 2020;17(15):2338–2345. doi:10.7150/ijms.49078
   PubMed Web of Science ®Google Scholar
• Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(Suppl 1):3–15. doi:10.1111/dom.14007
   PubMed Web of Science ®Google Scholar
• Chen Z, Wu H, Wang G, et al. Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile. BMC Nephrol. 2016;17(1):149. doi:10.1186/s12882-016-0366-8
   PubMedGoogle Scholar
• Vettoretti S, Caldiroli L, Zanoni F, et al. Patients with hypertensive nephropathy and chronic kidney disease might not benefit from strict blood pressure control. Kidney Blood Press Res. 2018;43(6):1706–1715. doi:10.1159/000495388
   PubMed Web of Science ®Google Scholar
• Levin A, Agarwal R, Herrington WG, et al. International consensus definitions of clinical trial outcomes for kidney failure: 2020. Kidney Int. 2020;98(4):849–859. doi:10.1016/j.kint.2020.07.013
   PubMed Web of Science ®Google Scholar
• Shen Y, Cai R, Sun J, et al. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine. 2017;55(1):66–76. doi:10.1007/s12020-016-1014-6
   PubMed Web of Science ®Google Scholar
• Kim Y, Park CW. Can management of the components of metabolic syndrome modify the course of chronic kidney disease?. Kidney Res Clin Pract. 2020;39(2):118–120. doi:10.23876/j.krcp.20.066
   PubMed Web of Science ®Google Scholar
• Tonneijck L, Muskiet MH, Smits MM, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023–1039. doi:10.1681/ASN.2016060666
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC State-of-The-Art review. J Am Coll Cardiol. 2019;74(14):1823–1838. doi:10.1016/j.jacc.2019.08.1017
   PubMed Web of Science ®Google Scholar
• Qian Q. Inflammation: a key contributor to the genesis and progression of chronic kidney disease. Contrib Nephrol. 2017;191:72–83.
   PubMed Web of Science ®Google Scholar
• O’Sullivan ED, Hughes J, Ferenbach DA. Renal aging: causes and consequences. J Am Soc Nephrol. 2017;28(2):407–420. doi:10.1681/ASN.2015121308
   PubMed Web of Science ®Google Scholar
• Milan-Mattos JC, Anibal FF, Perseguini NM, et al. Effects of natural aging and gender on pro-inflammatory markers. Braz J Med Biol Res. 2019;52(9):e8392. doi:10.1590/1414-431x20198392
   PubMed Web of Science ®Google Scholar
• Guan Y, Zhang C, Lyu G, et al. Senescence-activated enhancer landscape orchestrates the senescence-associated secretory phenotype in murine fibroblasts. Nucleic Acids Res. 2020;48(19):10909–10923. doi:10.1093/nar/gkaa858
   PubMed Web of Science ®Google Scholar
• Xiao L, Harrison DG. Inflammation in hypertension. Can J Cardiol. 2020;36(5):635–647. doi:10.1016/j.cjca.2020.01.013
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Gender-specific associations between insulin resistance, hypertension, and markers of inflammation among adult Saudis with and without diabetes mellitus type 2. Adv Med Sci. 2010;55(2):179–185. doi:10.2478/v10039-010-0052-1
   PubMed Web of Science ®Google Scholar
• Cohen E, Margalit I, Shochat T, et al. Markers of chronic inflammation in overweight and obese individuals and the role of gender: a cross-sectional study of a large cohort. J Inflamm Res. 2021;14:567–573. doi:10.2147/JIR.S294368
   PubMed Web of Science ®Google Scholar
• Festa A, D’Agostino Jr RJ, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25(10):1407–1415. doi:10.1038/sj.ijo.0801792
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Rifai N, et al. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999;100(7):713–716. doi:10.1161/01.CIR.100.7.713
   PubMed Web of Science ®Google Scholar
• Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 1999;100(7):717–722. doi:10.1161/01.CIR.100.7.717
   PubMed Web of Science ®Google Scholar